Integrated Traditional Chinese Medicine Assisted Hepatic Artery Infusion in Treatment of 43 Cases of Primary Liver Cancer at Middle and Advanced Stages
|更新时间:2024-01-04
|
Integrated Traditional Chinese Medicine Assisted Hepatic Artery Infusion in Treatment of 43 Cases of Primary Liver Cancer at Middle and Advanced Stages
Chinese Journal of Experimental Traditional Medical FormulaeVol. 20, Issue 15, Pages: 195-199(2014)
GUO Meng, ZHANG Cheng-hui, XU Yun, et al. Integrated Traditional Chinese Medicine Assisted Hepatic Artery Infusion in Treatment of 43 Cases of Primary Liver Cancer at Middle and Advanced Stages[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(15): 195-199.
DOI:
GUO Meng, ZHANG Cheng-hui, XU Yun, et al. Integrated Traditional Chinese Medicine Assisted Hepatic Artery Infusion in Treatment of 43 Cases of Primary Liver Cancer at Middle and Advanced Stages[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(15): 195-199. DOI: 10.13422/j.cnki.syfjx.2014150195.
Integrated Traditional Chinese Medicine Assisted Hepatic Artery Infusion in Treatment of 43 Cases of Primary Liver Cancer at Middle and Advanced Stages
Objective: To discuss short-term effects of adjuvant therapy of integrated traditional Chinese medicine therapy combined with transcatheter chemoembolization in treating primary hepatic carcinoma at middle and advanced stages and influence to patients' quality of life
immunity and metastasis rate. Method: Eighty-three patients were divided into control group (40 cases) and observation group (43 cases) by different methods of treatment.Patients in the control group received Hepatic arterial infusion chemotherapy and embolization(TACE) operation(drugs including pirarubicin
fluorouracil
mitomycin and super liquefaction iodinated oil)
repeated one time for every four weeks
two times in total
after operation
patients got symptomatic and supportive treatment of liver protection and stomach protection.Based on the treatment of the control group
patients in the observation group received elemene injections with 0.4-0.6 g/time
intravenous infusion
used for 3 weeks
stoped for 1 week and used for 3 weeks finally;Shenmai injections with 60 mL/time
intravenous infusion
used for 2 weeks after TACE operation;Jiedu Xiaoai decoctions with 1dose/day
conventional water frying
taken divides 2-3 times.Course of treatment in two groups were both 8 weeks.After treatment
size change of solid tumor was observed by CT or nuclear magnetic resonance imaging(MRI);Before and after treatment
score was evaluated by the European organization for cancer research and treatment of core quality of life scale-C30 (EORTCQLQ-C30)and quality of life
levels of peripheral blood T-lymphocyte subsets(CD3+
CD4+
CD4+/CD8+) and natural killer(NK) cell were detected by flow cytometry
levels of blood vessel endothelial growth factors (VEGF)
intercellular adhesion molecule-1(ICAM-1) and blood α-fetoprotein(AFP) were detected. Result: Effective rate of curative efficacy of solid tumor in the observation group was 93% superior to 77.5% in the control group(P<0.05).After treatment
levels of T-lymphocyte subsets(CD3+
CD4+
CD4+/CD8+) and NK cell in the control group showed downtrend
but those in the observation group increased(P<0.05 or P<0.01)
levels of CD3+
CD4+
CD4+/CD8+ and NK in the observation group were higher than those in the control group(P<0.01)
except cognitive function
other dimension scores in the observation group were increased(P<0.01)
which were higher than those in the control group(P<0.05 or P<0.01)
dimension scores of tired
pain
nausea and vomiting
agrypnia and appetite loss in the observation group were lower than those in the control group(P<0.01)
levels of AFP
ICAM-1 and VEGV in the observation group were lower than those in the control group(P<0.01). Conclusion: Elemene injections
Shenmai injections(intravenous infusion) and Jiedu Xiaoai decoctions(taken orally) combined with TACE could get synergism in treating primary hepatic carcinoma at middle and advanced stages
and it could improve patients' quality of life and immunity
relieve state of an illness
there may be a inhibiting effect of neoplasm metastasis.
Mechanism of Kidney-tonifying and Liver-regulating Cyclical Therapy and Formula in Improving Endometrial Receptivity during "Implantation Window" in Rats with Polycystic Ovary Syndrome via miR-140-5p/VEGF Pathway
Protective Effect of Taohong Siwutang on Cerebral Ischemia-reperfusion Injury Based on A1/A2 Phenotype Transformation of Astrocytes Mediated by JAK2/STAT3 Pathway
Effect of Xiao Xianxiongtang on 5-FU-mediated Myocardial Fibrosis and Protein Expression of HIF-1α/VEGF Signaling Pathway in Mice
Effect of Component Compatibility of Gentianae Macrophyllae Radix and Clematidis Radix et Rhizoma on Serum Inflammatory Factors and Expression of NF-κB and VEGF in Ankle Joint of Rats with Rheumatoid Arthritis
Mechanism of Cordycepin Inhibiting Proliferation and Promoting Apoptosis of Hepatoma Cells by Regulating Gli1
Related Author
LIU Quan
HE Yiqing
ZHANG Ying
WANG Xi
YANG Shuo
WANG Huifang
CHEN Xinru
CHEN Mengyuan
Related Institution
Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, Hunan University of Chinese Medicine
Hunan University of Chinese Medicine
MOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials
Anhui Province Key Laboratory of Chinese Medicinal Formula
School of Pharmacy,Anhui University of Chinese Medicine